echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Green Valley Pharmaceuticals was exploded in Alzheimer’s drug phase 9 and the first commercial team resigned in large numbers, and the company responded that “partially false

    Green Valley Pharmaceuticals was exploded in Alzheimer’s drug phase 9 and the first commercial team resigned in large numbers, and the company responded that “partially false

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Reporter | Shen Jiaojiao

    Edit | Xie Xin










    Previously, Green Valley Pharmaceuticals launched a plan to invest 3 billion US dollars in early 2020, saying that it will support the ninth phase one post-marketing real-world research, the international multi-center phase Ⅲ clinical research "green memory", the expansion of indication research and mechanisms for in-depth research






    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.